Cite
HARVARD Citation
Even, C. et al. (n.d.). 1065PTOPNIVO: A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): First results on behalf of the UNICANCER Head&Neck Group and the GORTEC. Annals of oncology. p. . [Online].